Relafen Ds Tablet
Product Images NDC 15370-170

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Relafen Ds (NDC 15370-170). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Carwin Pharmaceutical Associates, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Nabumetone 01)

Chemical structure of nabumetone, the active ingredient in RELAFEN DS 1000 mg oral tablets. The diagram shows the molecular structure with aromatic rings, a methoxy group, and a ketone functional group.*

FDA Label Image

Chemical Structure (Nabumetone 02)

Chemical structure of nabumetone, the active ingredient in RELAFEN DS 1000 mg oral tablets. The structure includes methoxy, naphthalene, and carboxylic acid functional groups.*

FDA Label Image

Figure (Nabumetone 03)

A line graph depicting the concentration of a substance (mg/mL) over time (hours) up to 70 hours. The graph includes four curves representing two standard deviations above and below the mean concentrations for 1000 mg and 2000 mg doses, with vertical lines indicating 1000 mg/day and 2000 mg/day dosage points.*

FDA Label Image

Principal Display Panel (1,000 mg Tablet Bottle Label)

Label for RELAFEN DS (nabumetone) 1000 mg tablets, oral dosage form, with a quantity of 30 tablets. The label includes usage instructions, storage conditions, pharmacist dispensing instructions, and manufacturer information for Carwin Pharmaceutical Associates, LLC. The NDC number 15370-170-30 is displayed alongside a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.